The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer

Journal of Gastrointestinal Surgery

Volumn 13, Issue 7, 2009, Pages 1337-1344

  Riediger, Hartwig ^a   Keck, Tobias ^a   Wellner, Ulrich ^a   Zur Hausen, Axel ^a   Adam, Ulrich ^a   Hopt, Ulrich T ^a   Makowiec, Frank ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Lymph node ratio; Pancreatic cancer; Prognostic factors; Resection; Survival

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CANCER STAGING; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PANCREAS RESECTION; PANCREAS TUMOR; PANCREATICODUODENECTOMY; PATHOLOGY; PREDICTION AND FORECASTING; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICS; SURVIVAL; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 67349211755     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-009-0919-2     Document Type: Article

References (27)

1. MG House M Gonen WR Jarnagin M D'Angelica RP Dematteo Y Fong MF Brennan PJ Allen 2007 Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer J Gastrointest Surg. 11 1549 1555 10.1007/s11605-007-0243-7
2. JM Winter JL Cameron KA Campbell MA Arnold DC Chang J Coleman MB Hodgin PK Sauter RH Hruban TS Riall RD Schulick MA Choti KD Lillemoe CJ Yeo 2006 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience J Gastrointest Surg. 10 1199 1210 10.1016/j.gassur.2006.08.018
3. A Richter M Niedergethmann JW Sturm D Lorenz S Post M Trede 2003 Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience World J Surg. 27 324 329 10.1007/s00268-002-6659-z
4. JF Tseng CP Raut JE Lee PW Pisters JN Vauthey EK Abdalla HF Gomez CC Sun CH Crane RA Wolff DB Evans 2004 Pancreaticoduodenectomy with vascular resection: margin status and survival duration J Gastrointest Surg. 8 935 949 10.1016/j.gassur.2004.09.046
5. CJ Yeo JL Cameron KD Lillemoe TA Sohn KA Campbell PK Sauter J Coleman RA Abrams RH Hruban 2002 Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality Ann Surg. 236 355 366 10.1097/00000658-200209000-00012
6. TS Riall JL Cameron KD Lillemoe KA Campbell PK Sauter J Coleman RA Abrams D Laheru RH Hruban CJ Yeo 2005 Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma-part 3: update on 5-year survival J Gastrointest Surg. 9 1191 1206 10.1016/j.gassur.2005.08.034
7. S Pedrazzoli V DiCarlo R Dionigi F Mosca P Pederzoli C Pasquali G Kloppel K Dhaene F Michelassi 1998 Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group Ann Surg. 228 508 517 10.1097/00000658-199810000- 00007
8. JP Neoptolemos JA Dunn DD Stocken J Almond K Link H Beger C Bassi M Falconi P Pederzoli C Dervenis L Fernandez-Cruz F Lacaine A Pap D Spooner DJ Kerr H Friess MW Buchler 2001 Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial Lancet. 358 1576 1585 10.1016/S0140-6736(01)06651-X
9. H Oettle S Post P Neuhaus K Gellert J Langrehr K Ridwelski H Schramm J Fahlke C Zuelke C Burkart K Gutberlet E Kettner H Schmalenberg K Weigang-Koehler WO Bechstein M Niedergethmann I Schmidt-Wolf L Roll B Doerken H Riess 2007 Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial JAMA. 297 267 277 10.1001/jama.297.3.267
10. JE Lim MW Chien CC Earle 2003 Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients Ann Surg. 237 74 85 10.1097/00000658-200301000-00011
11. TM Breslin KR Hess DB Harbison ME Jean KR Cleary AP Dackiw RA Wolff JL Abbruzzese NA Janjan CH Crane JN Vauthey JE Lee PW Pisters DB Evans 2001 Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration Ann Surg Oncol. 8 123 132 10.1007/s10434-001- 0123-4 (Pubitemid 32199408)
12. MF Brennan MW Kattan D Klimstra K Conlon 2004 Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas Ann Surg. 240 293 298 10.1097/01.sla.0000133125.85489.07
13. TA Sohn CJ Yeo JL Cameron L Koniaris S Kaushal RA Abrams PK Sauter J Coleman RH Hruban KD Lillemoe 2000 Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators J Gastrointest Surg. 4 567 579 10.1016/S1091-255X(00)80105-5
14. H Riediger F Makowiec E Fischer U Adam UT Hopt 2006 Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection J Gastrointest Surg. 10 1106 1115 10.1016/j.gassur.2006.04.002
15. TM Pawlik AL Gleisner JL Cameron JM Winter L Assumpcao KD Lillemoe C Wolfgang RH Hruban RD Schulick CJ Yeo MA Choti 2007 Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer Surgery. 141 610 618 10.1016/j.surg.2006.12.013
16. AC Berger JC Watson EA Ross JP Hoffman 2004 The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma Am Surg. 70 235 240
17. M Sierzega T Popiela J Kulig K Nowak 2006 The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer Pancreas. 33 240 245 10.1097/01.mpa.0000235306.96486.2a
18. U Adam F Makowiec H Riediger WD Schareck S Benz UT Hopt 2004 Risk factors for complications after pancreatic head resection Am J Surg. 187 201 208 10.1016/j.amjsurg.2003.11.004
19. TM Breslin KR Hess DB Harbison ME Jean KR Cleary AP Dackiw RA Wolff JL Abbruzzese NA Janjan CH Crane JN Vauthey JE Lee PW Pisters DB Evans 2001 Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration Ann Surg Oncol. 8 123 132 10.1007/s10434-001- 0123-4 (Pubitemid 32199408)
20. O Ishikawa H Ohhigashi Y Sasaki T Kabuto I Fukuda H Furukawa S Imaoka T Iwanaga 1988 Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head Ann Surg. 208 215 220 10.1097/00000658-198808000-00014 (Pubitemid 18200402)
21. T Manabe G Ohshio N Baba T Miyashita N Asano K Tamura K Yamaki A Nonaka T Tobe 1989 Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas Cancer. 64 1132 1137 doi:10.1002/1097-0142(19890901)64:5<1132::AID- CNCR2820640528>3.0.CO;2-V (Pubitemid 19208870)
22. D Bogoevski F Onken A Koenig JT Kaifi P Schurr G Sauter JR Izbicki EF Yekebas 2008 Is it time for a new TNM classification in esophageal carcinoma? Ann Surg. 247 633 641 10.1097/SLA.0b013e3181656d07
23. BP Wijnhoven KT Tran A Esterman DI Watson HW Tilanus 2007 An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus Ann Surg. 245 717 725 10.1097/01.sla.0000251703.35919.02
24. E Bando Y Yonemura K Taniguchi S Fushida T Fujimura K Miwa 2002 Outcome of ratio of lymph node metastasis in gastric carcinoma Ann Surg Oncol. 9 775 784
25. A Sierra FM Regueira JL Hernandez-Lizoain F Pardo MA Martinez-Gonzalez J Cienfuegos 2003 Role of the extended lymphadenectomy in gastric cancer surgery: experience in a single institution Ann Surg Oncol. 10 219 226 10.1245/ASO.2003.07.009
26. R Rosenberg J Friederichs T Schuster R Gertler M Maak K Becker A Grebner K Ulm H Hofler H Nekarda JR Siewert 2008 Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period Ann Surg. 248 968 978 10.1097/SLA. 0b013e318190eddc
27. D Bogoevski EF Yekebas P Schurr JT Kaifi A Kutup A Erbersdobler K Pantel JR Izbicki 2004 Mode of spread in the early phase of lymphatic metastasis in pancreatic ductal adenocarcinoma: prognostic significance of nodal microinvolvement Ann Surg. 240 993 1000 10.1097/01.sla.0000145922.25106.e3